Life Sciences Market Research Reports

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 08 Nov 2016  |  North America  |  Market Research

    The US Molecular Diagnostics Market, Forecast to 2021

    Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye

    The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

    $4,950.00
  2. 13 Sep 2016  |  North America  |  Market Research

    US Next-generation Sequencing Services Market

    $1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects

    The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...

    $4,950.00
  3. 25 Jul 2016  |  North America  |  Market Research

    US Hospital Cybersecurity Market—2015–2021

    Healthcare Gears Up to Combat the Growing Risk of Cyber Attacks

    The report describes and defines the market for various types of solutions (products and services) deployed by US hospitals to protect the security of enterprise information technology (IT) systems and the privacy and security of patient information; covers key factors driving the need to deploy these solutions in response to dynamic industry shift...

    $4,950.00
  4. 15 Jul 2016  |  Europe  |  Market Research

    Snapshot of the Mobile Health (mHealth) Market Opportunity in Europe

    Sector Convergence is Generating Growth Opportunities Across the Value Chain

    Mobile Health (mHealth) can play a vital role in European healthcare systems by improving communication between providers and patients and enabling patients to participate more actively in their health and wellness. At both EU and country levels, various pilot projects have demonstrated positive outcomes—both qualitative and quantitative—result...

    $1,500.00
  5. 12 Jul 2016  |  Asia Pacific  |  Market Research

    Analysis of the APAC Health Information Exchange Market

     

    This research service analyzes the health information exchange (HIE) market in Asia-Pacific. Driven primarily by governments, the region is embarking on the next phase of healthcare IT transformation, investing in decentralizing patient information by enabling data exchange among established electronic medical record (EMR) and electronic health rec...

    $4,950.00
  6. 11 Jul 2016  |  Global  |  Technology Research

    Therapeutic Advances in Pain Management (TechVision)

     

    This research service covers key technological trends and developments across global analgesic products and technologies that are likely to have a high impact in the near future. Based on the observation of the global analgesic industry, advances and technological trends across existing and emerging technologies have been detailed. While providing ...

    $4,950.00
  7. 08 Jul 2016  |  North America  |  Market Research

    Digital Health Grows Up- Is Pharma Guiding the Way?

    Frost & Sullivan reviews key themes and industry trends from the 5th Annual Digital Health Summer Summit and BIO International held in June 2016. Major topics covered include the use of virtual and augmented reality in medical education and clinical care; new digital health technologies to improve mental health; investor perspectives on the market ...

    $1,500.00
  8. 07 Jul 2016  |  Global  |  Technology Research

    Regenerative Medicine - The Future of Therapy (TechVision)

    After many years of basic research, regenerative medicine represents a remarkable foremost innovation in medical care. Comprising principles of stem cell technology and tissue engineering, also combining advanced biomaterials with small molecules and biologics, to replace or regenerate human tissues and organs and restore their functions, regenerat...

    $4,950.00
  9. 01 Jul 2016  |  Europe  |  Market Research

    Western Europe Point-of-Care Testing (POCT) Market

    Point-of-care testing is an integral part of the IVD market that is rapidly evolving into a preferred testing mode in the EU region. POCT is a segment that presents growth opportunities for a cross-section of players, ranging from OEMs to data integrators to technology vendors. The stakeholders need to be abreast of the challenges posed by the indu...

    $4,950.00
  10. 30 Jun 2016  |  Global  |  Market Research

    Growth and Expansion of Regenerative Medicine Market

     

    The market for regenerative medicine, one of the fastest growing segments in the biotechnology industry, is estimated to reach $67.5 billion by 2020 recording a compound annual growth rate (CAGR) of 22%. Current industry trends signal the expanding horizons of regenerative medicine, with its application being explored in new therapeutic segments su...

    $1,500.00